“There’s actually pretty widespread variability in these clinical measures, even between the reference labs,” said Eric Schadt, chairman of genetics and genomic

“There’s actually pretty widespread variability in these clinical measures, even between the reference labs,” said Eric Schadt, chairman of genetics and genomic sciences at the Icahn School and an author of the report. “But Theranos was more outside of range and outside of range in ways that would impact clinical decision-making.”